{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Physique nucléaire : Questions médicales les plus fréquentes",
"headline": "Physique nucléaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Physique nucléaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-24",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Physique nucléaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Physique",
"url": "https://questionsmedicales.fr/mesh/D010825",
"about": {
"@type": "MedicalCondition",
"name": "Physique",
"code": {
"@type": "MedicalCode",
"code": "D010825",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Théorie quantique",
"alternateName": "Quantum Theory",
"url": "https://questionsmedicales.fr/mesh/D011789",
"about": {
"@type": "MedicalCondition",
"name": "Théorie quantique",
"code": {
"@type": "MedicalCode",
"code": "D011789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671.579.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Théorie de la fonctionnelle de la densité",
"alternateName": "Density Functional Theory",
"url": "https://questionsmedicales.fr/mesh/D000077318",
"about": {
"@type": "MedicalCondition",
"name": "Théorie de la fonctionnelle de la densité",
"code": {
"@type": "MedicalCode",
"code": "D000077318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671.579.800.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Physique nucléaire",
"alternateName": "Nuclear Physics",
"code": {
"@type": "MedicalCode",
"code": "D009686",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bart W Hoogenboom",
"url": "https://questionsmedicales.fr/author/Bart%20W%20Hoogenboom",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics and Astronomy; Institute for the Physics of Living Systems; London Centre for Nanotechnology, University College London, London, United Kingdom. Electronic address: b.hoogenboom@ucl.ac.uk."
}
},
{
"@type": "Person",
"name": "Anton Zilman",
"url": "https://questionsmedicales.fr/author/Anton%20Zilman",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, University of Toronto, Toronto, Ontario, Canada; Institute for Biomedical Engineering, Toronto, Ontario, Canada. Electronic address: zilmana@physics.utoronto.ca."
}
},
{
"@type": "Person",
"name": "Jan Lammerding",
"url": "https://questionsmedicales.fr/author/Jan%20Lammerding",
"affiliation": {
"@type": "Organization",
"name": "Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA; Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA. Electronic address: jan.lammerding@cornell.edu."
}
},
{
"@type": "Person",
"name": "Pavel Hozák",
"url": "https://questionsmedicales.fr/author/Pavel%20Hoz%C3%A1k",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology of the Cell Nucleus, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., 142 20, Prague, Czech Republic; Department of Epigenetics of the Cell Nucleus, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., division BIOCEV, 25250, Vestec, Czech Republic; Microscopy Centre, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., 142 20, Prague, Czech Republic. Electronic address: hozak@img.cas.cz."
}
},
{
"@type": "Person",
"name": "Symeon Siniossoglou",
"url": "https://questionsmedicales.fr/author/Symeon%20Siniossoglou",
"affiliation": {
"@type": "Organization",
"name": "Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines des sciences naturelles",
"item": "https://questionsmedicales.fr/mesh/D010811"
},
{
"@type": "ListItem",
"position": 3,
"name": "Physique",
"item": "https://questionsmedicales.fr/mesh/D010825"
},
{
"@type": "ListItem",
"position": 4,
"name": "Physique nucléaire",
"item": "https://questionsmedicales.fr/mesh/D009686"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Physique nucléaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Physique nucléaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Physique nucléaire",
"description": "Comment la physique nucléaire aide-t-elle au diagnostic médical ?\nQuels tests utilisent la physique nucléaire pour le cancer ?\nQu'est-ce que la radiographie ?\nQuels sont les marqueurs radioactifs ?\nComment la physique nucléaire aide-t-elle en cardiologie ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Physique nucléaire",
"description": "Quels symptômes peuvent indiquer une exposition aux radiations ?\nComment reconnaître une maladie liée aux radiations ?\nQuels signes d'alerte pour une intoxication radioactive ?\nQuels symptômes d'une surdose de radiothérapie ?\nQuels symptômes d'une maladie thyroïdienne causée par radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Physique nucléaire",
"description": "Comment prévenir l'exposition aux radiations ?\nQuelles sont les recommandations pour les travailleurs exposés ?\nComment réduire les risques de cancer par radiothérapie ?\nQuelles mesures de sécurité en médecine nucléaire ?\nComment se préparer à une scintigraphie ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Physique nucléaire",
"description": "Quels traitements utilisent la physique nucléaire ?\nComment fonctionne la radiothérapie ?\nQu'est-ce que la thérapie par isotopes ?\nQuels sont les effets secondaires de la radiothérapie ?\nComment la médecine nucléaire traite-t-elle le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Physique nucléaire",
"description": "Quelles complications peuvent survenir après une radiothérapie ?\nQuels risques à long terme de la radiothérapie ?\nQuelles complications de la médecine nucléaire ?\nComment gérer les effets secondaires de la radiothérapie ?\nQuels sont les effets à long terme des radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Physique nucléaire",
"description": "Quels sont les facteurs de risque de cancer lié aux radiations ?\nComment l'environnement influence-t-il le risque de radiations ?\nQuels comportements augmentent le risque de maladies liées aux radiations ?\nQuel rôle joue la génétique dans le risque de cancer ?\nComment l'âge affecte-t-il le risque de maladies liées aux radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la physique nucléaire aide-t-elle au diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet l'utilisation d'imageries comme la TEP et la scintigraphie pour diagnostiquer des maladies."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la physique nucléaire pour le cancer ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La scintigraphie et la TEP sont couramment utilisées pour détecter et évaluer le cancer."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la radiographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une technique d'imagerie utilisant des rayons X pour visualiser les structures internes du corps."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs radioactifs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ce sont des substances radioactives utilisées pour suivre des processus biologiques dans le corps."
}
},
{
"@type": "Question",
"name": "Comment la physique nucléaire aide-t-elle en cardiologie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet des tests comme la scintigraphie myocardique pour évaluer la fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une exposition aux radiations ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vomissements, fatigue, et brûlures cutanées peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une maladie liée aux radiations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales, des saignements et des infections fréquentes peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour une intoxication radioactive ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue extrême, perte de cheveux, et troubles neurologiques peuvent être des signes d'intoxication."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une surdose de radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeurs cutanées, douleurs, et fatigue excessive peuvent indiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie thyroïdienne causée par radiations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des changements de poids, fatigue, et troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux radiations ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection, limiter le temps d'exposition et maintenir une distance sûre."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs exposés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent suivre des protocoles de sécurité stricts et subir des contrôles réguliers de santé."
}
},
{
"@type": "Question",
"name": "Comment réduire les risques de cancer par radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer soigneusement les bénéfices et les risques avant de commencer le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité en médecine nucléaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des dispositifs de protection, surveiller les doses et former le personnel adéquatement."
}
},
{
"@type": "Question",
"name": "Comment se préparer à une scintigraphie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les instructions du médecin, éviter certains aliments et hydrater avant l'examen."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent la physique nucléaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie et la médecine nucléaire sont des traitements courants pour le cancer."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la radiothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle utilise des rayonnements pour détruire les cellules cancéreuses tout en épargnant les tissus sains."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie par isotopes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement utilisant des isotopes radioactifs pour cibler des cellules malades, comme dans l'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la radiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets incluent fatigue, nausées, et irritations cutanées, selon la zone traitée."
}
},
{
"@type": "Question",
"name": "Comment la médecine nucléaire traite-t-elle le cancer ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle utilise des agents radioactifs pour cibler et détruire les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections, des saignements et des dommages aux tissus peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques à long terme de la radiothérapie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de développer un cancer secondaire et des problèmes cardiaques peut augmenter."
}
},
{
"@type": "Question",
"name": "Quelles complications de la médecine nucléaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques aux agents radioactifs et des effets indésirables peuvent se produire."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires de la radiothérapie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de soutien, une bonne hydratation et des médicaments peuvent aider à gérer les effets."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme des radiations ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes de fertilité, des maladies cardiovasculaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de cancer lié aux radiations ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition professionnelle, les antécédents familiaux et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque de radiations ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les zones à forte radioactivité naturelle ou industrielle augmentent le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de maladies liées aux radiations ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fumer, consommer de l'alcool et négliger les contrôles médicaux réguliers peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le risque de cancer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques peuvent prédisposer les individus à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le risque de maladies liées aux radiations ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont souvent plus sensibles aux effets des radiations en raison de la dégradation cellulaire."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...